Stanley Meresman has served as a member of Guardant Health’s board of directors since May 2018. During the last ten years, Mr. Meresman has served on the boards of directors of various public and private companies, including service as chair of the audit committee for some of these companies. He currently serves on the board of directors, and as chair of the audit committee, of Snap, Inc. Previously, he served as a member of the board of directors, and chair of the audit committee, of Palo Alto Networks, Inc. from December 2014 to December 2018, LinkedIn Corporation from October 2010 to December 2016, Zynga Inc. from June 2011 to June 2015, Meru Networks, Inc. from September 2010 to May 2013, and Riverbed Technology, Inc. from March 2005 to May 2012. He also currently serves on the board, and as audit committee chair, of several private companies. From January 2004 to December 2004, Mr. Meresman was a Venture Partner with Technology Crossover Ventures, a private equity firm, and was General Partner and Chief Operating Officer of Technology Crossover Ventures from November 2001 to December 2003. During the four years before joining Technology Crossover Ventures, he was a private investor and board member and adviser to several technology companies. From May 1989 to May 1997, Mr. Meresman served as the Senior Vice President and Chief Financial Officer of Silicon Graphics, Inc. Mr. Meresman holds a B.S. degree in industrial engineering and operations research from the University of California, Berkeley and an M.B.A. degree from the Stanford Graduate School of Business.
What is Stanley J. Meresman's net worth?
The estimated net worth of Stanley J. Meresman is at least $112,650.19 as of May 24th, 2023. Mr. Meresman owns 3,557 shares of Guardant Health stock worth more than $112,650 as of December 21st. This net worth evaluation does not reflect any other investments that Mr. Meresman may own. Learn More about Stanley J. Meresman's net worth.
How do I contact Stanley J. Meresman?
Has Stanley J. Meresman been buying or selling shares of Guardant Health?
Stanley J. Meresman has not been actively trading shares of Guardant Health over the course of the past ninety days. Most recently, Stanley J. Meresman sold 4,934 shares of the business's stock in a transaction on Thursday, March 10th. The shares were sold at an average price of $58.74, for a transaction totalling $289,823.16. Learn More on Stanley J. Meresman's trading history.
Who are Guardant Health's active insiders?
Are insiders buying or selling shares of Guardant Health?
During the last year, Guardant Health insiders bought shares 1 times. They purchased a total of 2,187 shares worth more than $38,972.34. During the last year, insiders at the sold shares 6 times. They sold a total of 5,632 shares worth more than $180,115.00. The most recent insider tranaction occured on December, 18th when Director Musa Tariq sold 116 shares worth more than $4,042.60. Insiders at Guardant Health own 5.5% of the company.
Learn More about insider trades at Guardant Health. Information on this page was last updated on 12/18/2024.
